Segmental Erythema Multiforme-Like Drug Eruption by Aromatase Inhibitor Anastrozole – First Case Report and another Example of an Immunocompromised District

Anastrozole is a non-selective aromatase inhibitor for adjuvant breast cancer therapy in postmenopausal women. Cutaneous adverse events have been reported. We observed a 64-year-old female patient with a medical history of locally advanced breast cancer of her right breast that was treated with radi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wollina, Uwe, Schönlebe, Jacqueline, Heinig, Birgit, Tchernev, Georgi, França, Katlein, Lotti, Torello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816324/
https://www.ncbi.nlm.nih.gov/pubmed/29483990
http://dx.doi.org/10.3889/oamjms.2018.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816324/
https://www.ncbi.nlm.nih.gov/pubmed/29483990
http://dx.doi.org/10.3889/oamjms.2018.026

Ejemplares similares